Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-05-15

Clinical Trial Update: Safety and Tolerability of Zipsor® in Pediatric Subjects (Ages 12-17 Years) With Mild to Moderate Acute [Phase 4]

View source ↗

Summary

Clinical trial update reporting safety and tolerability of Zipsor in pediatric patients aged 12-17 with mild to moderate acute pain; study completed with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZIPSOR (diclofenac potassium)

Snippet

Sponsor: Depomed | Conditions: Pain | Phase 4 | Status: COMPLETED | Results posted: 2015-05-15